GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and...

A new discovery that explains how the body’s immune system makes a potent antibody that blocks HIV infection may be an important step toward developing a vaccine against the virus.
Scientists from the National Institute of Allergy and Infectious Diseases analyzed data from the results of a clinical trial of the only experimental HIV vaccine to date that’s shown modest success in people. Trial results showed that...

Novavax ($NVAX) and Novartis ($NVS) have both been racing to bring to market a vaccine for the avian H7N9 flu, which has caused more than 130 infections and 43 deaths in China. But in the absence of an approved vaccine, researchers at Kansas State University think they’ve found an existing antiviral drug that could squelch the infection.
H7N9 viruses are resistant to antiviral flu drugs like Tamiflu or Relenza, which...

QuantuMDx is taking their handheld diagnostic tool to the masses, and hoping to raise $50,000 in an Indiegogo campaign starting today. The money will support a malaria clinical trial in Africa.
The tool can differentiate strains of drug-resistant malaria in the field, says co-founder and CSO Jonathan O’Halloran, helping public health workers immediately identify which treatments to use, and if it’s safe for infected...

The antibiotics arena hasn’t proved lucrative enough for Big Pharma, leading to a mass exodus from the field in recent years. But pharma companies may have a reason to get back in the antibiotics game.
A group of bipartisan members in the House of Representatives introduced a bill late Thursday that aims to combat the growing threat of so-called “superbugs” by essentially providing a fast-track route to FDA...

Scientists from the Uniformed Services University of the Health Sciences (USU) have developed a new preparation method that renders a virus or bacterium non-infectious while preserving its immune-boosting ability after exposure to gamma radiation. A lethally irradiated vaccine was successfully tested in mice against drug-resistant Staphylococcus aureus bacteria by colleagues at the National Institutes of Health (NIH), and...